Jarek Baran

Prof. Jarek Baran

Jagiellonian University Medical College, Faculty of Medicine, Institute of Pediatrics, Department of Clinical Immunology
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RSRafał Szatanek
Rafał Szatanek
MBMonika Baj-Krzyworzeka
Monika Baj-Krzyworzeka
JZJakub Zimoch
Jakub Zimoch
MLMalgorzata Lekka
Malgorzata Lekka
MSMaciej Siedlar
Maciej Siedlar
Jarek BaranJarek Baran
Jarek Baran
In recent years, extracellular vesicles (EVs) have become a subject of intense study. These membrane-enclosed spherical structures are secreted by almost every cell type and are engaged in the transport of cellular content (cargo) from parental to target cells. The impact of EVs transfer has been observed in many vital cellular processes including cell-to-cell communication and immune response modulation; thus, a fast and precise characterization of EVs may be relevant for both scientific and diagnostic purposes. In this review, the most popular analytical techniques used in EVs studies are presented with the emphasis on exosomes and microvesicles characterization.

9 November 2005 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
MBMonika Baj-Krzyworzeka
Monika Baj-Krzyworzeka
RSRafał Szatanek
Rafał Szatanek
KWKazimierz Węglarczyk
Kazimierz Węglarczyk
Jarek BaranJarek Baran
Jarek Baran
BUBarbara Urbanowicz
Barbara Urbanowicz
MZMarek Zembala
Marek Zembala

Verified
Journal Article
Open access
PDF file
BKBartosz Klebowski
Bartosz Klebowski
JDJoanna Depciuch
Joanna Depciuch
MPMagdalena Parlinska-Wojtan
Magdalena Parlinska-Wojtan
Jarek BaranJarek Baran
Jarek Baran
Nanoparticles have unique, size-dependent properties, which means they are widely used in various branches of industry. The ability to control the properties of nanoparticles makes these nanomaterials very interesting for medicine and pharmacology. The application of nanoparticles in medicine is associated with the design of specific nanostructures, which can be used as novel diagnostic and therapeutic modalities. There are a lot of applications of nanoparticles, e.g., as drug delivery systems, radiosensitizers in radiation or proton therapy, in bioimaging, or as bactericides/fungicides. This paper aims to introduce the characteristics of noble metal-based nanoparticles with particular emphasis on their applications in medicine and related sciences.

22 April 2015 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
RSRafal Szatanek
Rafal Szatanek
Jarek BaranJarek Baran
Jarek Baran
MSMaciej Siedlar
Maciej Siedlar
MBMonika Baj-Krzyworzeka
Monika Baj-Krzyworzeka
The discovery of extracellular vesicles (EVs) has revised the interpretation of intercellular communication. It is now well established that EVs play a significant role in coagulation, inflammation, cancer and stem cell renewal and expansion. Their release presents an intriguing, transporting/trafficking network of biologically active molecules, which are able to reach and modulate the function/behavior of the target cells in a variety of ways. Moreover, the presence of EVs in various body fluids points to their potential for use as biomarkers and prognostic indicators in the surveillance/monitoring of a variety of diseases. Although vast knowledge on the subject of EVs has accumulated over the years, there are still fundamental issues associated with the correct approach for their isolation. This review comprises the knowledge on EV isolation techniques that are currently available. The aim of this reveiw was to make both experienced researchers and newcomers to the field aware that different types of EVs require unique isolation approaches. The realization of this ‘uniqueness’ is the first step in the right direction for the complete assessment of EVs.

31 December 2009 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
Jarek BaranJarek Baran
Jarek Baran
MBMonika Baj-Krzyworzeka
Monika Baj-Krzyworzeka
KWKazimierz Weglarczyk
Kazimierz Weglarczyk
RSRafal Szatanek
Rafal Szatanek
MZMaria Zembala
Maria Zembala
MZMarek Zembala
Marek Zembala

7 August 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ISIzabela Sieminska
Izabela Sieminska
Jarek BaranJarek Baran
Jarek Baran
Colorectal cancer (CRC) remains one of the most common malignancies diagnosed worldwide. The pathogenesis of CRC is complex and involves, among others, accumulation of genetic predispositions and epigenetic factors, dietary habits, alterations in gut microbiota, and lack of physical activity. A growing body of evidence suggests that immune cells play different roles in CRC, comprising both pro- and anti-tumorigenic functions. Immunosuppression observed during cancer development and progression is a result of the orchestration of many cell types, including myeloid-derived suppressor cells (MDSCs). MDSCs, along with other cells, stimulate tumor growth, angiogenesis, and formation of metastases. This article focuses on MDSCs in relation to their role in the initiation and progression of CRC. Possible forms of immunotherapies targeting MDSCs in CRC are also discussed.